ATE394475T1 - Methode zur herstellung von infektiösem reovirus - Google Patents

Methode zur herstellung von infektiösem reovirus

Info

Publication number: ATE394475T1
Authority: AT; Austria
Prior art keywords: producing infectious; infectious reovirus; reovirus; producing; infectious
Prior art date: 2000-08-10

Application number

AT05009952T

Other languages

English (en)

Inventor

Matthew C Coffey

Bradley G Thompson

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-10

Filing date

2001-07-20

Publication date

2008-05-15

2001-07-20 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE394475T1 publication Critical patent/ATE394475T1/de

Links

241000702263 Reovirus sp. Species 0.000 title 1
208000015181 infectious disease Diseases 0.000 title 1
230000002458 infectious effect Effects 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Mycology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT05009952T 2000-08-10 2001-07-20 Methode zur herstellung von infektiösem reovirus ATE394475T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22402600P	2000-08-10	2000-08-10

Publications (1)

Publication Number	Publication Date
ATE394475T1 true ATE394475T1 (de)	2008-05-15

Family

ID=22838987

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT01953084T ATE298788T1 (de)	2000-08-10	2001-07-20	Verfahren zur herstellung von infektiösen reoviren
AT05009952T ATE394475T1 (de)	2000-08-10	2001-07-20	Methode zur herstellung von infektiösem reovirus

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT01953084T ATE298788T1 (de)	2000-08-10	2001-07-20	Verfahren zur herstellung von infektiösen reoviren

Country Status (18)

Country	Link
US (4)	US6528305B2 (de)
EP (2)	EP1586634B1 (de)
JP (2)	JP4009532B2 (de)
AR (1)	AR033993A1 (de)
AT (2)	ATE298788T1 (de)
AU (2)	AU7562801A (de)
BR (1)	BR0113122A (de)
CA (1)	CA2415749C (de)
DE (2)	DE60111747T2 (de)
DK (2)	DK1309672T3 (de)
ES (2)	ES2305940T3 (de)
IL (2)	IL153847A0 (de)
MX (1)	MXPA03000846A (de)
NZ (1)	NZ523510A (de)
PT (2)	PT1586634E (de)
TW (1)	TWI289158B (de)
WO (1)	WO2002012435A1 (de)
ZA (1)	ZA200300410B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6545492B1 (en) *	1999-09-20	2003-04-08	Europaisches Laboratorium Fur Molekularbiologie (Embl)	Multiple local probe measuring device and method
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus
IL157304A0 (en)	2001-03-16	2004-02-19	Oncolytics Biotech Inc	Method of extracting virus from cell culture
US20040115170A1 (en) *	2001-11-30	2004-06-17	Brown Earl Garnet	Oncolytic virus
CA2374388C (en) *	2002-02-28	2005-07-12	Matthew C. Coffey	The use of ribozymes in the detection of adventitious agents
US20040005546A1 (en)	2002-02-28	2004-01-08	Oncolytics Biotech Inc.	Use of ribozymes in the detection of adventitious agents
US7235393B2 (en) *	2002-04-29	2007-06-26	The Trustees Of The University Of Pennsylvania	Method for direct rescue and amplification of integrated viruses from cellular DNA of tissues
DE60327069D1 (de) *	2002-04-30	2009-05-20	Oncolytics Biotech Inc	Verbesserte reinigungsmethode für viren
NZ536102A (en) *	2002-05-09	2008-01-31	Oncolytics Biotech Inc	Oncolytic viruses, in particular reovirus, for reducing pain associated with proliferative disorders, particularly with the growth of a solid tumour mass
EP1944035A1 (de)	2002-05-09	2008-07-16	Oncolytics Biotech Inc.	Verfahren zur Schmerzlinderung durch onkolytische Viren
PT1505993E (pt) *	2002-05-10	2012-05-15	Oncolytics Biotech Inc	Sensibilização de células neoplásicas a terapia de radiação com vírus oncolíticos
US7901921B2 (en)	2004-10-22	2011-03-08	Oncolytics Biotech Inc.	Viral purification methods
US7600514B2 (en) *	2005-06-17	2009-10-13	Nellcor Puritan Bennett Llc	System and method for securing a gas delivery mask onto a subject's head
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
WO2007099401A2 (en)	2005-08-01	2007-09-07	University Technologies International, Inc.	Oncolytic attenuated reoviruses for treatment of proliferative disorders
DK1984007T3 (en) *	2006-02-13	2015-12-07	Oncolytics Biotech Inc	Application of Low-dose local immunosuppression for amplification of viral oncolytic therapy
US8293498B2 (en)	2006-12-20	2012-10-23	Vanderbilt University	System for generation of viable reovirus from cloned cDNA
WO2008127486A2 (en) *	2006-12-29	2008-10-23	Bacilligen, Inc.	Replication-proficient dsrna capsids and uses thereof
SG191602A1 (en) *	2007-03-12	2013-07-31	Oncolytics Biotech Inc	Reoviruses having modified sequences
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
AR066649A1 (es) *	2007-05-21	2009-09-02	Oncolytics Biotech Inc	Reovirus mutantes y metodos de elaboracion y uso de los mismos
AU2008316276A1 (en) *	2007-10-22	2009-04-30	Oncolytics Biotech Inc.	Treatment regime for proliferative disorders
US20110086005A1 (en) *	2008-05-27	2011-04-14	Oncolytics Biotech Inc.	Modulating interstitial pressure and oncolytic viral delivery and distribution
TW200950777A (en) *	2008-05-27	2009-12-16	Oncolytics Biotech Inc	Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
WO2011126976A1 (en)	2010-04-07	2011-10-13	Vanderbilt University	Reovirus vaccines and methods of use therefor
SG184833A1 (en)	2010-04-14	2012-11-29	Emd Millipore Corp	Methods of producing high titer, high purity virus stocks and methods of use thereof
MX373096B (es)	2010-12-02	2020-04-27	Oncolytics Biotech Inc	Formulaciones virales líquidas.
CA2819236A1 (en) *	2010-12-02	2012-06-07	Oncolytics Biotech Inc.	Lyophilized viral formulations
ES2796950T3 (es)	2013-11-15	2020-11-30	Oncolytics Biotech Inc	Virus oncolíticos y regímenes reforzados para tratamiento de cáncer
CN112143693B (zh) *	2019-06-28	2024-12-27	杭州康万达医药科技有限公司	一种生产病毒的方法及收获液组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4070453A (en) *	1976-06-25	1978-01-24	Syntex (U.S.A.) Inc.	Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines
US4559229A (en) *	1982-07-20	1985-12-17	Research Foundation	Avian proventriculitis vaccine
US5023252A (en)	1985-12-04	1991-06-11	Conrex Pharmaceutical Corporation	Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja)	1986-08-11	1988-02-25	Biseibutsu Kagaku Kenkyusho:Kk	豚のレオウイルス感染症ワクチン
US5658779A (en) *	1992-03-20	1997-08-19	Ligochem, Inc.	Method of adsorbing viruses from fluid compositions
JPH08214876A (ja)	1995-02-15	1996-08-27	Chemo Sero Therapeut Res Inst	ウイルスの調製法
EP0968284B1 (de) *	1996-11-20	2006-12-13	Introgen Therapeutics, Inc.	Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
KR20010020308A (ko)	1997-06-24	2001-03-15	스타르크, 카르크	4,4'-디할로겐디페닐설폰을 제조하는 방법
US6136307A (en) *	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
AR028039A1 (es)	2000-05-03	2003-04-23	Oncolytics Biotech Inc	Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
TWI289158B (en) *	2000-08-10	2007-11-01	Oncolytics Biotech Inc	Method of producing infectious reovirus

2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en not_active Ceased
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/de not_active Expired - Lifetime
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 EP EP01953084A patent/EP1309672B1/de not_active Expired - Lifetime
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
2003
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
AU2001275628B2 (en)	2007-08-30
US20060165724A1 (en)	2006-07-27
JP2006314336A (ja)	2006-11-24
HK1082765A1 (en)	2006-06-16
ES2241844T3 (es)	2005-11-01
DE60111747T2 (de)	2006-04-27
PT1586634E (pt)	2008-06-19
PT1309672E (pt)	2005-09-30
IL153847A (en)	2007-10-31
DK1586634T3 (da)	2008-08-18
US7049127B2 (en)	2006-05-23
BR0113122A (pt)	2003-07-22
DE60133947D1 (de)	2008-06-19
US7429485B2 (en)	2008-09-30
US20030166253A1 (en)	2003-09-04
EP1586634A1 (de)	2005-10-19
IL153847A0 (en)	2003-07-31
US20040126869A1 (en)	2004-07-01
WO2002012435A1 (en)	2002-02-14
US6703232B2 (en)	2004-03-09
AR033993A1 (es)	2004-01-21
AU2001275628B8 (en)	2002-02-18
EP1586634B1 (de)	2008-05-07
CA2415749A1 (en)	2002-02-14
TWI289158B (en)	2007-11-01
EP1309672A1 (de)	2003-05-14
DE60111747D1 (de)	2005-08-04
US6528305B2 (en)	2003-03-04
JP4009532B2 (ja)	2007-11-14
NZ523510A (en)	2004-08-27
ES2305940T3 (es)	2008-11-01
AU7562801A (en)	2002-02-18
CA2415749C (en)	2009-05-12
JP2004505623A (ja)	2004-02-26
ATE298788T1 (de)	2005-07-15
EP1309672B1 (de)	2005-06-29
US20020037576A1 (en)	2002-03-28
DK1309672T3 (da)	2005-10-10
ZA200300410B (en)	2004-01-26
MXPA03000846A (es)	2004-04-05

Legal Events

Date

Code

Title

Description

2008-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1586634

Country of ref document: EP

2010-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60133947D1 (de)	2008-06-19	Methode zur Herstellung von infektiösem Reovirus
ATE398174T1 (de)	2008-07-15	Methode zur herstellung funktioneller proteindomänen
DE60221399D1 (de)	2007-09-06	Verfahren zur herstellung von mitteldistillaten
ATE222899T1 (de)	2002-09-15	Verfahren zur herstellung von reinem citalopram
DE60033061D1 (de)	2007-03-08	Verfahren zur herstellung von siloxancopolycarbonaten
ATE453648T1 (de)	2010-01-15	Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
ATE281447T1 (de)	2004-11-15	Verfahren zur herstellung von citalopram
AT7110U9 (de)	2004-11-25	Verfahren zur herstellung von amlodipinmaleat
DE60105732D1 (de)	2004-10-28	Verfahren zur Herstellung von 3-l-Menthoxypropan-1,2-diol
DE60230908D1 (de)	2009-03-05	Verfahren zur herstellung von polyarylenethern
DE60217213D1 (de)	2007-02-15	Methode zur Herstellung einer Fotomaske
DE50101607D1 (de)	2004-04-08	Verfahren zur herstellung von bisphenolen
DE60238628D1 (de)	2011-01-27	Methode zur herstellung von kalzium glukonat
ATE506351T1 (de)	2011-05-15	Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
ATE296287T1 (de)	2005-06-15	Verfahren zur herstellung von repaglinide
DE50102444D1 (de)	2004-07-01	Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de)	2006-02-15	Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE50111560D1 (de)	2007-01-11	Verfahren zur herstellung von guerbetalkoholen
DE60103173D1 (de)	2004-06-09	Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
DE50200870D1 (de)	2004-09-23	Verfahren zur herstellung von hydroxyalkylpolysiloxanen
DE60123013T8 (de)	2007-09-20	Verfahren zur herstellung von glasskeramiken
ATE323677T1 (de)	2006-05-15	Verfahren zur herstellung von 4-amino-2,5- bisheterocyclylchinazolinen
DE60105991D1 (de)	2004-11-04	Verfahren zur herstellung von 6-aminocapronamid
DE60135096D1 (de)	2008-09-11	Verfahren zur herstellung von tetrafluorethylen
ATE282031T1 (de)	2004-11-15	Verfahren zur herstellung von citalopram